Partnership model to address misconceptions and optimise first-line therapy for rheumatoid arthritis
Presented as an oral presentation at the National Medicines Symposium 2022
Translating evidence into practice through evidence-based resources for the management of Inflammatory Bowel Disease
Poster presentation for SHPA Medicines Management 2021 conference Objective: To identify knowledge gaps of health professionals around biologic treatment for inflammatory…
Engaging Clinicians and Consumers in the design and implementation of a National Education Program for Inflammatory Arthritis
Poster presentation at ARA Annual Scientific Meeting May 2022
Facilitating the translation of evidence into best practice: Optimising the pharmacological management of inflammatory arthritis
Therapeutic drug monitoring in inflammatory bowel disease
CATAG has developed this document to facilitate and support the translation of best available evidence into practice for the management…
What do Rheumatologists think and do in the management of Inflammatory Arthritis: A Baseline Survey
Presented at ARA Annual Scientific Meeting May 2021
Patterns of use of b/tsDMARDS and other medications for with Rheumatoid Arthritis: a retrospective study using PBS data
Presented at ARA Annual Scientific Meeting May 2021 Aims to describe prescribing patterns for biological/targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs)…
Initiating a National Consortium Approach to support optimal use of bDMARDs
Poster presented at ARA Annual Scientific Meeting May 2021